Related Experiment Video
Updated: Mar 28, 2026

03:10
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
Published on: November 1, 2024
3.9K
Bacteriological resistance in acne: A call to action
1CHU Nantes, Place Alexis Ricordeau, 44093 Cedex 01, France.
European Journal of Dermatology : EJD
|December 30, 2015
Summary
Antibiotic resistance in acne is a growing public health concern. Guidelines now recommend limiting antibiotic use and exploring alternatives to preserve their effectiveness.
Area of Science:
- Dermatology
- Microbiology
- Public Health
Background:
- Acne affects a significant portion of the adult population, with antibiotic therapies historically being a mainstay treatment.
- Increasing antibiotic resistance worldwide poses a major public health challenge, particularly in acne management due to large patient numbers and prolonged treatment durations.
- Overuse of antibiotics in acne treatment has led to rising resistance, necessitating a re-evaluation of current therapeutic strategies.
Purpose of the Study:
- To highlight the escalating issue of antibiotic resistance in acne treatment.
- To advocate for evidence-based guidelines and appropriate antibiotic use in managing acne.
- To encourage consideration of alternative acne treatments and revised antibiotic application protocols.
Main Methods:
- Review of existing literature on antibiotic resistance patterns in acne.
- Analysis of current treatment guidelines and their implications for antibiotic stewardship.
- Evaluation of recommended durations and combination therapies for topical and oral antibiotics.
Main Results:
- Antibiotic resistance to common topical agents like erythromycin and clindamycin has been documented since the 1970s and is increasing globally.
- Antibiotics are frequently overused in acne treatment, contributing significantly to the public health problem of resistance.
- Current evidence suggests topical antibiotics should not be used as monotherapy and combination use limited to four weeks.
- Oral antibiotics should also not be used as monotherapy, with combination therapy limited to four months.
Conclusions:
- Judicious and appropriate use of antibiotics is crucial to preserve their efficacy in acne management.
- Topical antibiotics should be limited to combination regimens for a maximum of four weeks.
- Oral antibiotics should be combined with topical retinoids or benzoyl peroxide for a maximum of four months.
- Greater physician awareness and adherence to guidelines are required to combat antibiotic resistance in acne treatment.
More Related Videos
Related Concept Videos
Acne Infection
40
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
40
The Skin Microbiota
39
The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
39
Defense Against Bacterial Pathogens
3.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.4K
Clinical Significance of Antibiotic Resistance
29
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Mechanism of Antibiotic Resistance in MRSA
78
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
78
Development of Antibiotic Resistance
1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K

